Obesity Drugs

2 articles

Scientist in a futuristic lab analyzing a GLP-1 drug vial with holographic displays showing molecular structures and patient data.

Cosmos & Space

Medicare offers $50 monthly GLP-1 access amid obesity drug competition

Starting July 1, 2026, eligible Medicare beneficiaries will pay just $50 a month for certain GLP-1 obesity drugs.

Marcus Cole·June 8, 2026

Eligible Medicare beneficiaries smiling as they receive prescription for weight-loss medication, symbolizing improved access and affordability.

Cosmos & Space

Medicare Unveils $50 Monthly Cap on Obesity Drugs

Starting in July, eligible Medicare beneficiaries will access GLP-1 weight-loss medications for a monthly cost of just $50, according to The Motley Fool .

Aram Sarkisian·June 1, 2026